Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2015, Article ID 265670, 5 pages
http://dx.doi.org/10.1155/2015/265670
Research Article

Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry

1Lalitha Super Speciality Hospital (P) Ltd., Heart and Brain Centre, Kothapet, Guntur, Andhra Pradesh 522001, India
2Apollo Hospitals, Plot No. 1 A, Bhat GIDC Estate, Gandhinagar, Gujarat 382428, India
3Yashfeen Cardiac Hospital, Navsari, Gujarat 396445, India
4Lions Sterling Super Specialty Hospital, Mehsana, Gujarat 384001, India
5Department of Clinical Trials, Sahajanand Medical Technologies Pvt. Ltd., Surat, Gujarat 395004, India

Received 9 July 2015; Revised 20 August 2015; Accepted 20 August 2015

Academic Editor: John A. Kern

Copyright © 2015 Anurag Polavarapu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Pyörälä, M. Laakso, and M. Uusitupa, “Diabetes and atherosclerosis: an epidemiologic view,” Diabetes/Metabolism Reviews, vol. 3, no. 2, pp. 463–524, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. S. B. King, “Surgery is preferred for the diabetic with multivessel disease,” Circulation, vol. 112, no. 10, pp. 1500–1515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Roffi and E. J. Topol, “Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes,” European Heart Journal, vol. 25, no. 3, pp. 190–198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Y. Goraya, C. L. Leibson, P. J. Palumbo et al., “Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study,” Journal of the American College of Cardiology, vol. 40, no. 5, pp. 946–953, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. E. Kip, D. P. Faxon, K. M. Detre, W. Yeh, S. F. Kelsey, and J. W. Currier, “Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute percutaneous transluminal coronary angioplasty registry,” Circulation, vol. 94, no. 8, pp. 1818–1825, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Mosseri, M. Nahir, Y. Rozenman et al., “Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease,” Cardiology, vol. 89, no. 2, pp. 103–110, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. R. Moreno and V. Fuster, “New aspects in the pathogenesis of diabetic atherothrombosis,” Journal of the American College of Cardiology, vol. 44, no. 12, pp. 2293–2300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Abizaid, M. A. Costa, M. Centemero et al., “Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the arterial revascularization therapy study (ARTS) trial,” Circulation, vol. 104, no. 5, pp. 533–538, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Kuntz, “Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma,” Circulation, vol. 99, no. 7, pp. 847–851, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation, World Health Organization, Geneva, Switzerland, 2006.
  11. D. E. Cutlip, S. Windecker, R. Mehran et al., “Clinical end points in coronary stent trials: a case for standardized definitions,” Circulation, vol. 115, no. 17, pp. 2344–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Elezi, A. Kastrati, J. Pache et al., “Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement,” Journal of the American College of Cardiology, vol. 32, no. 7, pp. 1866–1873, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Carrozza, R. E. Kuntz, R. F. Fishman, and D. S. Baim, “Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus,” Annals of Internal Medicine, vol. 118, no. 5, pp. 344–349, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Moussa, M. B. Leon, D. S. Baim et al., “Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy,” Circulation, vol. 109, no. 19, pp. 2273–2278, 2004. View at Publisher · View at Google Scholar
  15. R. Seabra-Gomes, “Percutaneous coronary interventions with drug eluting stents for diabetic patients,” Heart, vol. 92, no. 3, pp. 410–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Stettler, S. Allemann, M. Egger, S. Windecker, B. Meier, and P. Diem, “Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials,” Heart, vol. 92, no. 5, pp. 650–657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Daemen, P. Wenaweser, K. Tsuchida et al., “Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study,” The Lancet, vol. 369, no. 9562, pp. 667–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Sabaté, P. Jiménez-Quevedo, D. J. Angiolillo et al., “Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial,” Circulation, vol. 112, no. 14, pp. 2175–2183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Dibra, A. Kastrati, J. Mehilli et al., “Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients,” The New England Journal of Medicine, vol. 353, no. 7, pp. 663–670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Van Belle, C. Bauters, E. Hubert et al., “Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels,” Circulation, vol. 96, no. 5, pp. 1454–1460, 1997. View at Publisher · View at Google Scholar · View at Scopus